21/10/21 Investor Presentation - Morgans Scone Conference shows the US and GER, FR, UK market is far larger than AU. The first targets Primary Stroke Care and Comprehensive Stroke Care would be concentrated first.
As per 27/05/24 announcement roadmap on the far right in yellow. For Gen 1 US FDA would be first target market then CE for EU, subsequently TGA for AU.
15/11/23 AGM CEO Presentation:
21/10/21 Investor Presentation - Morgans Scone Conference
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.020(1.14%) |
Mkt cap ! $148.7M | |||
| Open | High | Low | Value | Volume |
| $1.75 | $1.78 | $1.74 | $22.49K | 12.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 572 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 740 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |